Category:
Description:
Indications:
-
Life
threatening ventricular dysrhythmias, less severe but symptomatic
ventricular dysrhythmias in select patients
-
Maintenance
of sinus rhythm following cardioversion in atrial fibrillation and/or
flutter (non FDA approved)
-
Suppression
of recurrent paroxysmal atrial fibrillation (non FDA approved)
Contraindications:
Precautions:
-
Pregnancy
category C; compatible with breast feeding; long-term effect on
nursing infant unknown
-
Post
MI, 1st degree AV block (unless ventricular rate controlled
by pacemaker)
-
Asymptomatic
premature ventricular contractions, digitalis intoxication
-
CHF,
myasthenia gravis, renal insufficiency, children
Adverse
Reactions (Side Effects):
-
CNS:
depression, dizziness, giddiness, hallucinations, headache, psychosis,
weakness
-
CV:
hypotension, 2nd degree heart block, ventricular
arrhythmias
-
GI:
abdominal pain, anorexia, bitter taste, diarrhea, hepatomegaly,
nausea, vomiting
-
HEME:
agranulocytosis, hemolytic anemia (rare), neutropenia,
thrombocytopenia
-
SKIN:
angioneurotic edema, flushing, pruritus, rash, urticaria
-
MISC:
lupus erythematosus-like syndrome (arthralgia, plueral or abdominal
pain, arthritis, pleural effusion, pericarditis, fever, chills, rash)
in up to 30% on long-term therapy
|
Dosage:
Administered
orally, intravenously, intramuscularly
-
Adult: PO 250-500mg every 3-6 hours; PO SR 500-1000mg every 6 hours,
usual dose 50 mg/kg/day, max 4g daily; IM 0.5-1g every 4-8 hours until
PO therapy possible; IV 1g INF over 25-30 minutes or 100-200mg daily
repeated every 5 minutes as needed to total dose of 1g as a loading
dose, followed by continuous INF of 1-6 mg/min, titrate to patient
response
-
Child: PO 15-50 mg/kg/day divided every 3-6 hours, max 4g daily; IM
20-30 mg/kg/day divided every 4-6 hours, max 4g daily; IV 3-6 mg/kg
INF over 5 minutes not to exceed 100mg daily as a loading dose, then
20-80 mcg/kg/minute as a continuous INF, max 4g daily
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks.
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Brookside Associates, LLC
All rights reserved
|